Dermapharm Holding SE posts strong results for Q3 2024, Arkopharma (France) back above prior-year EBITDA levels for first time Consolidated revenue up 2.7% to EUR 890.1 million. Growth in high-margin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback